Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

43.22 -1.35 (-3.03%)
Streaming Delayed Price Updated: 12:37 PM EDT, Aug 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
43 44 Next >
Unlocking the Growth Potential of HIMS & HERS HEALTH INC (NYSE:HIMS).
A fundamental analysis of (NYSE:HIMS): HIMS & HERS HEALTH INC (NYSE:HIMS) showing high EPS and FCF growth while beating expectations 
Via Chartmill
Trump's Drug Price Slash Plan Sparks Retail Buzz As Investors Eye Big Pharma Fallout
The proposal, citing a "Most Favored Nation Policy," fueled debate prompted some watchers to question the legality and feasibility of the move, while others speculated on its potential market impact. 
Via Stocktwits
Topics ETFs Government Stocks
Retail Bulls Face Off With Record Shorts In Hims & Hers After Q1 Beat
Short interest in Hims & Hers rose to a record high of 37%, continuing a four-week climb, even as the stock surged 42% last week. The company’s quarterly revenue more than doubled, surpassing analyst... 
Via Stocktwits
Topics Earnings
The Trade Desk, Walt Disney, And Hims & Hers Health Are Among Top 11 Large-Cap Gainers Last Week (May 5-May 9): Are The Others In Your Portfolio?
Top-performing large-cap stocks last week: TTD, HIMS, PODD, FTAI, ULS, UI, ROK, TOST, DIS, MCHP, and ARMK. Analysts raised price forecasts. 
Via Benzinga
Benzinga Bulls And Bears: IBM, Novavax, Arm Holdings — And UK Trade Deal Boosts Markets
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories. 
Via Benzinga
Massive Hims & Hers News: $1 Billion on AI and Acquisitions
Hims & Hers is getting $1 billion of rocket fuel. 
Via The Motley Fool
Topics Artificial Intelligence
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Hims & Hers Stock Surges On Strong Q1 Results, Falls After Convertible Note Offering
Hims & Hers Health shares have surged 17.4% this week. The company reported strong first-quarter earnings late Monday. 
Via Benzinga
1 Small-Cap Stock to Target This Week and 2 to Keep Off Your Radar
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a... 
Via StockStory
Hims & Hers Health, Inc. Prices Upsized $870.0 Million Convertible Senior Notes Offering to Accelerate Global Expansion and Utilization of AI in Healthcare
From Hims & Hers
Via Business Wire
Hims & Hers Stock's 100% Surge Is Squeezing Shorts And It Might Just Be Getting Started
Hedge funds shorting Hims & Hers Health Inc (NYSE:HIMS) may regret it - earnings with a positive surprise could lead to a short squeeze as stock continues to rise, up 96% in past month. 
Via Benzinga
Why IBD 50's No. 2 Stock, ADMA Biologics, Just Plummeted By Double Digits
The company makes immunoglobulin products using donated plasma. 
Via Investor's Business Daily
Topics Earnings
Hims & Hers Health Stock Is Sliding Thursday: What's Going On?
Hims & Hers Health Inc (NYSE:HIMS) shares are falling Thursday morning after the company announced a proposed convertible senior notes offering. 
Via Benzinga
Top 3 Health Care Stocks That Could Sink Your Portfolio In Q2
 
Via Benzinga
Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Accelerate Global Expansion and Utilization of AI in Healthcare
From Hims & Hers
Via Business Wire
Hims & Hers Appoints AI Expert and Former President and CTO at Cruise as Chief Technology Officer
From Hims & Hers
Via Business Wire
Hims & Hers Has a Superpower in Healthcare
This isn't just any growth stock. 
Via The Motley Fool
Hims & Hers Health Shocks Investors With a Long-Term Forecast, but Is the Stock a Buy?
Via The Motley Fool
Hims & Hers Stock Soars 32% Since Tuesday On Strong Q1 Earnings And Robust Outlook
Hims & Hers Health shares have surged 32.4% since Tuesday's session open. The stock is gaining following a standout first-quarter earnings report released late Monday. 
Via Benzinga
Why Novo Nordisk Stock Popped After Earnings
Buying Novo Nordisk stock looks like the cheapest way to invest in GLP-1 drugs. 
Via The Motley Fool
Why Is Hims & Hers Stock Skyrocketing?
Via The Motley Fool
Hims & Hers Jumps 18.2% on Incredible 111% Revenue Growth
Hims & Hers is on fire right now. 
Via The Motley Fool
Market Monitor May 7 ( Hims & Hers Health, Upwork UP - Palantir, Monderna DOWN)
Markets slide on vaccine regulation fears, trade uncertainty, and cautious earnings despite strong tech and consumer stock moves. 
Via Chartmill
2 Volatile Stocks Worth Your Attention and 1 to Steer Clear Of
Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced... 
Via StockStory
Hims & Hers Health (HIMS) Stock Trades Up, Here Is Why
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 20.2% in the afternoon session after the company reported strong first quarter 2025 results which significantly beat analysts'... 
Via StockStory
Topics Artificial Intelligence
Why Hims & Hers Stock Popped Tuesday, but Eli Lilly and Novo Nordisk Dropped
Good news for Hims & Hers stock spooks Lilly and Novo investors. 
Via The Motley Fool
Topics Earnings
Which stocks are most active on Tuesday?
These stocks are making the most noise in today's session. Stay tuned for the latest updates! 
Via Chartmill
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
HIMS Q1 Earnings Call: Personalized Care and New Partnerships Drive Upside, Guidance Signals Near-Term Transition
Telehealth company Hims & Hers Health (NYSE:HIMS) announced better-than-expected revenue in Q1 CY2025, with sales up 111% year on year to $586 million. Revenue guidance for the full year exceeded... 
Via StockStory
Hims & Hers Stock Rises on Fundamentals and Squeeze Potential
Hims & Hers stock is now giving investors another reason to consider it a buy for the coming months, as the latest quarterly earnings show momentum. 
Via MarketBeat
< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
43 44 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.